Kenvue Inc. operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. Its Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.

Kenvue Inc.

In a report released on August 7, Nik Modi from RBC Capital maintained a Hold rating on Kenvue, Inc., with a price target of $20.00. The company’s ...

RBC Capital Sticks to Its Hold Rating for Kenvue, Inc. (KVUE)

U.S. stocks finished a strong week with another rally on Friday after a surprisingly weak jobs report pushed investors to rethink the path for inte...

The Week That Was, The Week Ahead: Macro and Markets, August 9

Analysts fell to the sidelines weighing in on Vital Farms (VITL) and Kenvue, Inc. (KVUE) with neutral ratings, indicating that the experts are neit...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	KVUE	$18.79	0.00%	356
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	KVUE	$18.79	0%	356
3
4
5
6

KVUE

Get Kenvue Inc. Data in Excel

Get Kenvue Inc. Data in Excel